MARC details
| 000 -LEADER |
| fixed length control field |
03319cam a22003254i 4500 |
| 001 - CONTROL NUMBER |
| control field |
3102519 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
EG-NcFUE |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20201006112109.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
990202s2019 enka b 001 0 eng c |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9780367399856 (alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| Cancelled/invalid ISBN |
9780824702298 (hbk) |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
| Authentication code |
pcc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
615.7 |
| Edition number |
22 |
| Item number |
H. |
| 245 00 - TITLE STATEMENT |
| Title |
Handbook of drug metabolism / |
| Statement of responsibility, etc |
edited by Thomas F. Woolf. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
London : |
| Name of publisher, distributor, etc |
CRC Press, |
| Date of publication, distribution, etc |
2019. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xi, 596 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
26 cm |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
| Formatted contents note |
Part 1 Fundamental Aspects of Drug Metabolism 1. Pharmacokinetics of Drug Metabolites / Philip C. Smith -- 2 Oxidative Metabolic Bioactivation of Xenobiotics /Stéphane Mabic, Kay Castagnoli, and Neal Castagnoli, Jr. -- 3. Morphofunctional Aspects of the Hepatic Architecture: Functional and Subcellular Corelates / Felix A. de la lglesia, Donald G. Robertson, and Jeffrey R. Haskins The Cytochrome P450 Oxidative System / Paul R. Ortiz de Montellano -- 5. Transformation Enzymes: Oxidative: Non-P450 / Allen E. Rettie and Michael B. Fisher Transformation Reactions: Glucuronidation Brian Burchell Part 2 Factors Affecting Drug Metabolism Pharmacogenetics Ann K. Daly -- Inhibition of Drug Metabolizing Enzymes: Molecular und Biochermical F. Peter Guengerich 2. Metabolic Drug Interactions Wayne D. Hooper 10. Induction of Human Drug-Metabolizing Enzymes: Mechanisms and Implications Martin J. J. Ronis and Magnus Ingelman-Sundberg 11 Sites of Metabolism: Lung Garold S. Yost Part 3 Technologies 12 Applications of Heterologous Expressed and Purified Human Drug-Metabolizing Enzymes: An Industrial Perspective A. David Rodrigues 13 In Vivo and In Vitro Recombinant DNA Technology as a Powerful Tool in Drug Development Thomas Friedberg, C. J. Henderson, M. P. Pritchard, and C. R. Wolf 14 In Vitro Metabolism Subcellular Eractions Sean Ekins, Jukka Mäenpää, and Steven A. Wrighton 15 In Vitro Metabolism Hepatocytes Michael W. Sinz 16 The Isalated PerfusedLiver as a Tool in Drug Mctabolism Studies -- Michael W. SinZ 16 The Isolated Perfused Liver as a Tool in Drug Metabolism Studies Marián Kukan 17 Metabolic Models of Cytotoxicity Munir Pirmohamed and B. Kevin Park 18. In Vitro Metabolism: FMO and Related Oxygenations John R. Cashman 19 Applications of Caco-2 Cells in Drug Discovery and Development Shiyin Yee and Wesley W. Day 20. The Role of Nuclear Magnetic Resonance Spectroscopy in Drug Metabolism 1. D. Wilson, J. K. Nicholson, and J. C. Lindon -- Part 4 Metabolism in Drug Discovery and Development 21. Preclinical Drug Metabolism Studies and Strate gies Philip B. Inskeep and Wesley W. Day 22 Clinical Drug Metabolism Studies William F. Pool. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Metabolism. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmaceutical Preparations |
| General subdivision |
metabolism. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Woolf, Thomas F., |
| Dates associated with a name |
1955-, |
| Relator term |
editor. |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0647/99017637-d.html">http://www.loc.gov/catdir/enhancements/fy0647/99017637-d.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ocip |
| f |
19 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |